Company Profiles

driven by the PitchBook Platform

Acetylon Pharmaceuticals

Acetylon Pharmaceuticals
2008 FOUNDED
M&A STATUS
11-50 EMPLOYEES
M&A LATEST DEAL TYPE
$200M LATEST DEAL AMOUNT
$153M TOTAL AMOUNT RAISED
Description

Developer of small-molecule drugs. The company is developing next-generation selective small molecule histone deacetylase (HDAC) inhibitors, which allow for epigenetic regulation of gene and protein function for the treatment of patients with critical unmet medical needs.

Website:
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-Backed
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Primary Office
Seaport Center, 70 Fargo Street
Suite 205
Boston, MA 02210
United States
+1 (617) 245-1300
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Acetylon Pharmaceuticals’s full profile, request a free trial.

Acetylon Pharmaceuticals Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Merger/Acquisition 16-Dec-2016 $200M $153M 00000 Completed Generating Revenue
6. Corporate 29-Jul-2013 00000 00000 Completed Clinical Trials - Phase 1
5. Later Stage VC (Series B2) 09-Feb-2012 0000 000.00 00000 Completed Clinical Trials - Phase 1
4. Early Stage VC (Series B) 29-Jun-2011 0000 000.00 00000 Completed Startup
3. Grant 11-May-2011 00.00 00.00 Completed Startup
2. Grant 01-Oct-2010 $500k $9.2M Completed Startup
1. Early Stage VC (Series A) 08-Jan-2010 $9.2M $9.2M $17.4M Completed Startup
To view this company’s complete deal history including valuation and funding request access »

Acetylon Pharmaceuticals Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned
Series B2 0,000,000 00.000000 00 00.00 00.00 00 00.00 0.000
Series B 0,000,000 00.000000 00 00.00 00.00 00 00.00 00.000
Series A 7,250,000 $0.001000 8% $1 $1 1x $1 28%
To view this company’s complete Cap Table request access »

Acetylon Pharmaceuticals Executive Team (16)

Name Title Board
Seat
Contact
Info
Min Yang Director, Biomarker Development
Faye Seyedi Director, Drug Substance Manufacturing
Ken Jacobs Director, Program Management
Kailash Bhol Ph.D Senior Director, Preclinical Development
Denise Hayes Senior Director, Regulatory Affairs
You’re viewing 5 of 16 executives. Get the full list »

Acetylon Pharmaceuticals Board Members (8)

Name Representing Role Since Contact
Info
Bruce Downey JD Self Board Member 000 0000
Elena Prokupets Ph.D Self Board Member 000 0000
James Bradner MD Acetylon Pharmaceuticals Scientific Founder & Board Member 000 0000
Kenneth Anderson MD Acetylon Pharmaceuticals Scientific Founder & Board Member 000 0000
Marc Cohen Acetylon Pharmaceuticals Co-Founder & Chairman 000 0000

1 Former Board Members

You’re viewing 5 of 8 board members. Get the full list »